Antibe Therapeutics Inc.
ATBPF
$0.2156
$0.025613.47%
ATBPF
Valuation
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Market Cap
--
6.44M
45.02M
Enterprise Value
-6.82M
< -10.00M
> 0.00
Price/Earnings (TTM)
-0.82
-3.19
-0.05
Earnings Per Share Growth (TTM)
-16.43%
-28.29%
-16.43%
Price/Earnings To Growth (TTM)
--
--
--
Price/Sales (TTM)
--
0.01
0.01
Price/Book (Q)
0.58
0.31
2.09
Enterprise Value/Revenue (TTM)
--
-0.043
-0.019
Enterprise Value/EBITDA (TTM)
2.59
< 0.00
4.54
Enterprise Value/EBIT (TTM)
0.46
< 0.00
0.81
Dividends and Shares
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Shares Outstanding
52.65M
52.04M
52.65M
Dividend Per Share (Most Recent)
--
--
--
Dividend Per Share (TTM)
--
--
--
Dividend Yield (TTM)
--
--
--
Payout Ratio (TTM)
--
--
--
Price History
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Beta
-0.07
-0.16
0.99
1-Month Total Return
0.00%
< 0.00%
> 10.00%
3-Month Total Return
0.00%
< -10.00%
> 0.00%
6-Month Total Return
0.00%
< -10.00%
> 0.00%
Year to Date Total Return
0.00%
< -50.00%
> 0.00%
1-Year Total Return
13.47%
< -40.00%
> 20.00%
2-Year Total Return
-50.92%
-89.47%
> -20.00%
3-Year Total Return
-66.23%
-97.11%
-57.54%
5-Year Total Return
-95.03%
-95.85%
-59.13%
Profitability
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Operating Margin (TTM)
--
-917.73%
-917.73%
Profit Margin (TTM)
--
-900.91%
-900.91%
Management Effectiveness
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Return on Assets (TTM)
-19.00%
-19.00%
-15.79%
Return on Equity (TTM)
--
--
--
Income Statement
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Revenue (TTM)
--
2.22M
2.22M
Total Revenue (TTM)
--
2.22M
2.22M
Total Revenue Growth (Q YOY)
--
--
--
Revenue Per Share (TTM)
--
24.38
24.38
Gross Profit (TTM)
--
--
--
EBITDA (TTM)
-2.63M
-20.19M
-2.63M
EBIT (TTM)
-14.76M
-20.37M
-14.76M
Net Income (TTM)
-13.76M
-20.00M
-13.76M
Net Income Avl. to Common (TTM)
-13.76M
-20.00M
-13.76M
Earnings Growth (Q YOY)
0.04%
0.04%
> 40.00%
EPS Diluted (TTM)
-0.26
-0.39
-0.26
EPS Diluted Growth (Q YOY)
3.29%
1.56%
37.23%
Balance Sheet
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Cash and Short-Term Inv. (Q)
18.86M
18.86M
43.90M
Cash Per Share (Q)
0.36
0.36
0.84
Total Current Assets (Q)
21.27M
21.27M
49.15M
Total Assets (Q)
42.68M
42.68M
71.41M
Total Current Liabilities (Q)
2.12M
2.04M
3.76M
Total Debt (Q)
0.00
0.00
0.00
Total Liabilities (Q)
23.04M
22.46M
25.89M
Total Common Equity (Q)
19.64M
19.64M
45.52M
Total Preferred Equity (Q)
--
--
--
Total Equity (Q)
19.64M
19.64M
45.52M
Current Ratio (Q)
10.055
8.566
15.706
Book Value Per Share (Q)
0.37
0.37
0.87
Cash Flow
ATBPF
Low
2-Year Historical Range
ATBPF
Average
High
Cash from Operations (TTM)
-13.54M
-13.54M
-11.66M
Cash from Investing (TTM)
13.97M
< -20.00M
13.97M
Cash from Financing (TTM)
117.60K
< 0.00
117.60K
Net Change in Cash (TTM)
549.30K
-38.03M
549.30K
Levered Free Cash Flow (TTM)
-9.11M
-9.11M
-5.91M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
